Statement from University of St Andrews on Completion of Enrollment in REMox TB
Dr Stephen H. Gillespie MD DSc Sir James Black Professor of Medicine University of St Andrews University Chief Investigator For […]
Dr Stephen H. Gillespie MD DSc Sir James Black Professor of Medicine University of St Andrews University Chief Investigator For […]
Dr. Martin Springsklee Vice President – Head Global Medical Affairs Anti-Infectives at Bayer HealthCare We started our partnership with the
The TB Alliance and its partners have completed patient enrollment in REMox TB, a global Phase III clinical trial, which
Prof. Charles Mgone Executive Director of the European and Developing Countries Clinical Trials Partnership (EDCTP) The enrolment of volunteers in
“The GFINDER report shows a large retraction of public funding, especially for product development partnerships (PDPs), which will have devastating
London – A fresh round of funding cuts from rich nations in the wake of the global financial crisis threaten
The meeting was convened to catalogue expert opinion on the conduct of Phase 2 and Phase 3 clinical trials in
Almari Uys of the TB Alliance was interviewed on Lotus FM Radio in South Africa. Conradie discussed the recent collaboration
TB Alliance CEO, Dr. Mel Spigelman, was interviewed on Doctor Radio on Sirius. Those who think U.S. residents aren’t significantly
(Durban, SOUTH AFRICA,) The TB Alliance today announced the launch of a collaboration with the National Institute of Allergy and